 Valeant Pharmaceuticals International Inc and activist investor William Ackman plan to boost their offer for Allergan Inc by  a share people familiar with the matter said trying to keep the Botox maker from striking a rival deal The new bid could value Allergan at more than  billion increasing the offer by  billion That would make it the largest deal of the year if completed surpassing AbbVie Incs pending  billion acquisition of Shire PLC